A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
Clinical trial NCT02482298 · COMPLETED
Trial details
- NCT number
- NCT02482298
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2016-11-16
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.